FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology and namely to a method for producing immunoglobulins. The invention can be used in medicine. The method includes the division of human plasma into fractions to obtain a fraction and subsequent passage through anionic chromatography A, anionic chromatography B, and affinity chromatography C.
EFFECT: invention makes it possible to obtain an immunoglobulin suitable for intravenous administration.
17 cl, 1 dwg, 2 tbl, 18 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR CHROMATOGRAPHIC EXTRACTION AND PURIFICATION OF IMMUNOGLOBULINS | 2018 |
|
RU2694620C1 |
METHOD OF PRODUCING COMPLEX OF IgG, IgM AND IgA IMMUNOGLOBULINS FOR INTRAVENOUS ADMINISTRATION | 2012 |
|
RU2492176C1 |
HYDROXYAPATITE CHROMATOGRAPHY REMOVAL OF LARGE MOLECULAR WEIGHT AGGREGATES | 2004 |
|
RU2409591C2 |
REMOVAL OF AGGREGATES WITH HIGH MOLECULAR WEIGHT BY HYDROXYAPATITE CHROMATOGRAPHY | 2010 |
|
RU2573910C2 |
METHOD OF PREPARING IMMUNOGLOBULINS FOR INTRAVENOUS ADMINISTRATION AND OTHER IMMUNOGLOBULIN PREPARATIONS | 1999 |
|
RU2197500C2 |
METHOD FOR ISOLATING AUTOANTIBODIES OF IMMUNOGLOBULIN G SUBCLASSES TO IMMUNOREGULATORY CYTOKINE TUMOR NECROSIS FACTOR | 2017 |
|
RU2646807C1 |
METHOD FOR CLEANING RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR FOR MEDICAL USE | 2017 |
|
RU2683950C1 |
IMPROVING IMMUNOGLOBULIN AFFINITY CHROMATOGRAPHY BY THE APPLICATION OF PRE-CAPTURE FLOCULATION | 2020 |
|
RU2794431C1 |
METHOD OF PRODUCING HUMAN IMMUNOGLOBULIN | 2013 |
|
RU2614119C9 |
HUMAN IMMUNODEFICIENCY VIRUS REPRODUCTION INHIBITOR | 2009 |
|
RU2396278C1 |
Authors
Dates
2021-02-09—Published
2019-01-10—Filed